204 related articles for article (PubMed ID: 21540458)
1. Calcineurin-dependent negative regulation of CD94/NKG2A expression on naive CD8+ T cells.
Cho JH; Kim HO; Webster K; Palendira M; Hahm B; Kim KS; King C; Tangye SG; Sprent J
Blood; 2011 Jul; 118(1):116-28. PubMed ID: 21540458
[TBL] [Abstract][Full Text] [Related]
2. The role of TCR stimulation and TGF-beta in controlling the expression of CD94/NKG2A receptors on CD8 T cells.
Gunturi A; Berg RE; Crossley E; Murray S; Forman J
Eur J Immunol; 2005 Mar; 35(3):766-75. PubMed ID: 15714583
[TBL] [Abstract][Full Text] [Related]
3. CD94/NKG2A expression is associated with proliferative potential of CD8 T cells during persistent polyoma virus infection.
Byers AM; Andrews NP; Lukacher AE
J Immunol; 2006 May; 176(10):6121-9. PubMed ID: 16670321
[TBL] [Abstract][Full Text] [Related]
4. Viral and bacterial infections induce expression of multiple NK cell receptors in responding CD8(+) T cells.
McMahon CW; Zajac AJ; Jamieson AM; Corral L; Hammer GE; Ahmed R; Raulet DH
J Immunol; 2002 Aug; 169(3):1444-52. PubMed ID: 12133970
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of CD94/NKG2A inhibitory receptors on CD8+ T cells in HIV infection is more pronounced in subjects with detected viral load than in their aviraemic counterparts.
Zeddou M; Rahmouni S; Vandamme A; Jacobs N; Frippiat F; Leonard P; Schaaf-Lafontaine N; Vaira D; Boniver J; Moutschen M
Retrovirology; 2007 Oct; 4():72. PubMed ID: 17927817
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of interleukin-12 and interleukin-15 on expansion of NK cell receptor-expressing CD8+ T cells.
Sugita J; Tanaka J; Yasumoto A; Shiratori S; Wakasa K; Kikuchi M; Shigematsu A; Kondo T; Asaka M; Imamura M
Ann Hematol; 2010 Feb; 89(2):115-20. PubMed ID: 19578849
[TBL] [Abstract][Full Text] [Related]
8. NKG2A/CD94 Is a New Immune Receptor for HLA-G and Distinguishes Amino Acid Differences in the HLA-G Heavy Chain.
Hò GT; Celik AA; Huyton T; Hiemisch W; Blasczyk R; Simper GS; Bade-Doeding C
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575403
[TBL] [Abstract][Full Text] [Related]
9. HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells.
Mingari MC; Ponte M; Bertone S; Schiavetti F; Vitale C; Bellomo R; Moretta A; Moretta L
Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1172-7. PubMed ID: 9448304
[TBL] [Abstract][Full Text] [Related]
10. Implication for the CD94/NKG2A-Qa-1 system in the generation and function of ocular-induced splenic CD8+ regulatory T cells.
Chattopadhyay S; O'Rourke J; Cone RE
Int Immunol; 2008 Apr; 20(4):509-16. PubMed ID: 18359787
[TBL] [Abstract][Full Text] [Related]
11. Evidence of functional Cd94 polymorphism in a free-living house mouse population.
Knutsen LE; Dissen E; Saether PC; Bjørnsen EG; Piálek J; Storset AK; Boysen P
Immunogenetics; 2019 Apr; 71(4):321-333. PubMed ID: 30535636
[TBL] [Abstract][Full Text] [Related]
12. [Different responses of CD94/NKG2A-bright and CD94/NKG2A-dim NK cell subsets isolated from patients with multiple sclerosis to interferon-beta].
Li L; Deng YC; Zhao G
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jun; 23(6):533-5. PubMed ID: 17553351
[TBL] [Abstract][Full Text] [Related]
13. Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR alphabeta lymphocytes.
Arlettaz L; Villard J; de Rham C; Degermann S; Chapuis B; Huard B; Roosnek E
Eur J Immunol; 2004 Dec; 34(12):3456-64. PubMed ID: 15517612
[TBL] [Abstract][Full Text] [Related]
14. Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8
Abd Hamid M; Wang RZ; Yao X; Fan P; Li X; Chang XM; Feng Y; Jones S; Maldonado-Perez D; Waugh C; Verrill C; Simmons A; Cerundolo V; McMichael A; Conlon C; Wang X; Peng Y; Dong T
Cancer Immunol Res; 2019 Aug; 7(8):1293-1306. PubMed ID: 31213473
[TBL] [Abstract][Full Text] [Related]
15. Natural Killer Group 2A Expressed on Both Peripheral CD3
Yi RT; Niu YH; Liu HL; Zhang TY; Yang YC; Zhang Y; Yin DL; Chen TY; Zhao YR
J Interferon Cytokine Res; 2016 Dec; 36(12):689-697. PubMed ID: 27828717
[TBL] [Abstract][Full Text] [Related]
16. Association of CD94/NKG2A, CD94/NKG2C, and its ligand HLA-E polymorphisms with Behcet's disease.
Seo J; Park JS; Nam JH; Bang D; Sohn S; Lee ES; Park KS
Tissue Antigens; 2007 Oct; 70(4):307-13. PubMed ID: 17767552
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of NK receptors CD94 and NKG2A by T cells in rheumatoid arthritis patients in remission compared to active disease.
Walsh CE; Ryan EJ; O'Farrelly C; Golden-Mason L; FitzGerald O; Veale DJ; Bresnihan B; Fearon U
PLoS One; 2011; 6(11):e27182. PubMed ID: 22102879
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 induces the expression of functional inhibitory CD94/NKG2A receptors in human CD8+ T lymphocytes by a cAMP-dependent protein kinase A type I pathway.
Zeddou M; Greimers R; de Valensart N; Nayjib B; Tasken K; Boniver J; Moutschen M; Rahmouni S
Biochem Pharmacol; 2005 Sep; 70(5):714-24. PubMed ID: 15978547
[TBL] [Abstract][Full Text] [Related]
19. IL-12-dependent inducible expression of the CD94/NKG2A inhibitory receptor regulates CD94/NKG2C+ NK cell function.
Sáez-Borderías A; Romo N; Magri G; Gumá M; Angulo A; López-Botet M
J Immunol; 2009 Jan; 182(2):829-36. PubMed ID: 19124726
[TBL] [Abstract][Full Text] [Related]
20. The non-classical MHC class I molecule Qa-1(b) inhibits classical MHC class I-restricted cytotoxicity of cytotoxic T lymphocytes.
Lohwasser S; Kubota A; Salcedo M; Lian RH; Takei F
Int Immunol; 2001 Mar; 13(3):321-7. PubMed ID: 11222501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]